SEC Company Response from Sonoma Pharmaceuticals, Inc. (SNOA) (CIK 0001367083) (SNOA) — Dec 21, 2006
Sonoma Pharmaceuticals, Inc. (SNOA) (CIK 0001367083)
Date: Dec. 21, 2006 · CIK: 0001367083 · Accession: 0000950134-06-023574
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-135584
Letter
Oculus Innovative Sciences, Inc.
1129 N. McDowell Blvd.
Petaluma, California 94954
December 21, 2006
VIA FACSIMILE AND ELECTRONIC SUBMISSION
Securities and Exchange Commission
Division of Corporation Finance
100 Fifth Street, N.E.
Washington, D.C. 20549
Re:
Oculus Innovative Sciences, Inc. — Registration Statement — Form S-1
Registration Number: 333-135584
Ladies and Gentlemen:
Oculus Innovative Sciences, Inc. (the “Registrant”) hereby withdraws its request for acceleration of the effective date of the above-captioned registration statement on Form S-1 (as amended, the “Registration Statement”) submitted on December 21, 2006. The Registrant will resubmit its request for acceleration of the Registration Statement at a later time.
Sincerely,
Oculus Innovative Sciences, Inc.
Show Raw Text
CORRESP
1
filename1.htm
corresp
Oculus Innovative Sciences, Inc.
1129 N. McDowell Blvd.
Petaluma, California 94954
December 21, 2006
VIA FACSIMILE AND ELECTRONIC SUBMISSION
Securities and Exchange Commission
Division of Corporation Finance
100 Fifth Street, N.E.
Washington, D.C. 20549
Re:
Oculus Innovative Sciences, Inc. — Registration Statement — Form S-1
Registration Number: 333-135584
Ladies and Gentlemen:
Oculus Innovative Sciences, Inc. (the “Registrant”) hereby withdraws its request for
acceleration of the effective date of the above-captioned registration statement on Form S-1 (as
amended, the “Registration Statement”) submitted on
December 21, 2006. The Registrant will
resubmit its request for acceleration of the Registration Statement at a later time.
Sincerely,
Oculus Innovative Sciences, Inc.
By:
/s/ Robert E. Miller
Robert E. Miller
Chief Financial Officer
cc:
S. K. Burks, Esq.